LSI (Life Science Innovations Fund)

What LSI (Life Science Innovations Fund) does

LSI (Life Science Innovations Fund) is a pre-seed and seed-stage venture capital fund and incubator headquartered in Białystok, Poland, structured as a Polish limited partnership (Life Science Innovations sp. z o.o. sp. k.). The fund invests in early-stage life sciences startups across four verticals: healthcare (preventive medicine, cost-reduction technologies, patient solutions), environmental protection (climate-positive, clean energy, biodiversity), biotech (laboratory diagnostics, agriculture, food production), and medtech (medical devices, biomaterials, health IT). LSI's stated mission is to incubate disruptive life sciences innovations and scale them into global challengers, sourcing deals primarily through a website-based project submission process where founders submit pitch decks for evaluation.

The fund has deployed capital across approximately 11 portfolio companies, including Lumisep, Wheelstair, ISN Pharma, Lifeflow, AIDMED, Bioseco, MeWheel, Brainscan, ABAStroke, Hagi, and Health2Organ. LSI is led by a four-person team: CEO Paweł Wilski (MSc), General Partner Adam Cudny (MSc, CIMA, ACCA), and Investment Committee members Marcin Szumowski (PhD) and Piotr Jeleński (MSc, MBS). The fund's operations are co-financed by the European Regional Development Fund under the Smart Growth Operational Programme 2014-2020, and the fund publishes SFDR/ESG disclosures, positioning it within the EU sustainable finance framework.

As an investment vehicle, LSI generates returns through equity stakes in portfolio companies rather than product or service revenue. The fund has demonstrated access to international syndicates via a 2026 co-investment with TPG Life Sciences Innovations in Odyssey Therapeutics' $304 million IPO. Distribution is regional (Europe, anchored in Poland), with deal sourcing concentrated on a direct website submission channel rather than institutional LP-raised capital of meaningful scale.

Name

LSI (Life Science Innovations Fund)

Legal name

Life Science Innovations sp. z o.o. sp. k.

Website

https://lsifund.pl

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

LSI is a pre-seed and seed-stage venture capital fund based in Białystok, Poland, that incubates and invests in early-stage life sciences startups across healthcare, biotech, medtech, and environmental protection verticals, with operations co-financed by the European Regional Development Fund.

Ownership category

akta.pro rank

Product category

Venture Capital / Life Sciences Investment

NAICS

Other Financial Vehicles (525990)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Climate / Clean Tech & Decarbonization Funds (FSANAJAA), SDG / Thematic Sustainable Investment Funds (FSANAJAN)

Keywords

• Venture capital fund
• Life sciences investment
• Seed stage funding
• Startup incubation
• Healthcare venture capital

Headquarters

HQ city

Bialystok

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Investment Returns: LSI Fund generates returns through equity investments in early-stage life sciences companies, incubating them into global businesses. The fund operates as an investor and incubator, providing capital and support to portfolio companies in exchange for equity stakes.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

LSI Fund is a Polish venture capital and incubation fund that provides pre-seed and seed stage capital investments to early-stage life sciences startups. The fund invests in companies operating across four focus areas — healthcare, environmental protection, biotech, and medtech — and incubates them into global challengers through ongoing capital, mentorship, and scaling support.

Product overview

LSI (Life Science Innovations Fund) is a venture capital and incubation fund that invests in life sciences startups across four focus areas: healthcare (preventive medicine, cost-reduction technology, patient solutions), environmental protection (climate-positive innovations, clean energy, sustainability), biotech (laboratory diagnostics, agriculture, food production technology), and medtech (medical devices, diagnostics, biomaterials, health IT). The fund does not offer a single unified product but rather provides investment, incubation, and scaling support to portfolio companies including Lumisep, Wheelstair, ISN Pharma, LifeFlow, AIDMED, BioSeco, BrainScan, ABAStroke, Hagi, and Health2Organ.

Differentiator

Problem solved

Functional benefit

Products and services

• Investment and Incubation Services Capital investment and incubation services provided to early-stage life sciences startups in healthcare, environmental protection, biotech, and medtech sectors. Services include evaluation of project submissions with pitch decks, equity investment, and ongoing support during the investment period to scale portfolio companies into global challengers.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• EQT Life Sciences: Amsterdam-based life sciences venture capital arm of EQT, investing in European biotech, medtech, and digital health. Direct peer — comparable European footprint, life sciences focus, and growth-stage orientation.
• Seventure Partners: Paris-based VC with a dedicated health and life sciences franchise covering biotech, medtech, and digital health. Direct peer — comparable life sciences specialism and European presence.
• Forbion: Netherlands-based European life sciences VC investing across development stages with focus on biotech and medical devices. Direct comparable — same European life sciences VC thesis, similar stage range, comparable thematic scope.
• Kurma Partners: Paris-based European life sciences VC investing in biotech, medtech, and digital health across early and growth stages. Direct peer — comparable life sciences thematic breadth and European scope.
• BioGeneration Ventures: Dutch-based early-stage life sciences VC focused on biotech and medtech in the Benelux and broader Europe. Direct peer — early-stage life sciences specialism directly aligns with LSI's pre-seed/seed mandate.
• Medicxi: Swiss/UK-based life sciences VC investing in early- and late-stage therapeutics and medical technology companies across Europe. Direct peer — same life sciences specialism with comparable stage coverage and European geographic focus.
• Sofinnova Partners: Paris-based, Europe-leading life sciences venture capital firm investing across all stages (seed through late-stage) of therapeutics and medtech. Directly comparable as a Europe-based life sciences specialist VC with comparable thematic breadth (biopharma, medtech, digital health).

Regional players

• Inovo VC: Poland-based early-stage VC investing in tech-enabled businesses including healthtech and biotech adjacencies. Regional peer — Poland-domiciled, early-stage focus overlapping with LSI's geographic and stage profile.
• Movens Capital: Poland-based early- and growth-stage VC with healthtech and life sciences exposure. Regional peer — same Polish base and early-stage orientation, providing regional benchmarking for deal sourcing and exit dynamics.
• SpeedUp Venture Capital Group: Poland-based venture capital firm with early-stage investments across sectors including digital health and life sciences. Regional peer — same Polish geography, comparable early-stage orientation, though broader sector mandate than LSI.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LSI (Life Science Innovations Fund)